CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 33 filers reported holding CATALYST BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $290,000 | -13.9% | 66,951 | 0.0% | 0.03% | -31.8% |
| Q1 2021 | $337,000 | -20.1% | 66,951 | 0.0% | 0.04% | -18.5% |
| Q4 2020 | $422,000 | +46.5% | 66,951 | 0.0% | 0.05% | -6.9% |
| Q3 2020 | $288,000 | -26.7% | 66,951 | 0.0% | 0.06% | -24.7% |
| Q2 2020 | $393,000 | +34.1% | 66,951 | 0.0% | 0.08% | -51.6% |
| Q1 2020 | $293,000 | -35.7% | 66,951 | 0.0% | 0.16% | -3.0% |
| Q4 2019 | $456,000 | – | 66,951 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |